Global In Vitro Diagnostics Market Research Report
PRODUCT TITLE | PUBLISHED | |
---|---|---|
Asia Immunoassay Asian immunoassay market is growing in double digit and will continue to grow in future. China commanded the largest share 53% of the Asian immunoassay market at an estimated $626.0 million in 2013 and is expected to reach $1309.0 million by 2018, at a CAGR of 16.7% from 2013 to 2018. The report “Asian Immunoassay Market forecast for 2018 “analyzes the market by two segments such as reagents and end instruments. |
Upcoming | |
Asia Microbiology Asian Microbiology market is growing in double digit and will continue to grow in future. China commanded the largest share 53% at an estimated $177.1 million in 2013 and is expected to reach $334.5 million by 2018, at a CAGR of 14.2% from 2013 to 2018. The report “Asian Microbiology Market forecast for 2018 “analyzes the market by two segments such as microbiology instruments and microbiology reagents. |
Upcoming | |
North America Microbiology The Americas commanded the largest share 42% of the Global Microbiology Market at an estimated $1485.02 million in 2013 and are expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018. The report “North American Microbiology Market forecast for 2018 “analyzes the market by two segments such as instruments and reagents. |
Upcoming | |
Europe Molecular Diagnostics Next to America, Europe holds second largest market position. Germany commanded the largest share 20% at an estimated $311.3 million in 2013 and is expected to reach $454.3 million by 2018, at a CAGR of 8.2% from 2013 to 2018. The report “European Molecular Diagnostics Market forecast for 2018 “analyzes the market by 2 segments such as instruments and reagents. |
Upcoming | |
Asia Molecular Diagnostics Asian Molecular Diagnostics market is growing in double digit and will continue to grow in future. China commanded the largest share 53% at an estimated $246.5 million in 2013 and is expected to reach $557.5 million by 2018, at a CAGR of 18.5% from 2013 to 2018. The report “Asian Molecular Diagnostics Market forecast for 2018 “analyzes the market by 2 segments such as instruments and reagents. |
Upcoming | |
North America Molecular Diagnostics The Americas commanded the largest share 42% of the Global Molecular Diagnostics Market at an estimated $2066.7 million in 2013 and are expected to reach $3221.4 million by 2018, at a CAGR of 9.7% from 2013 to 2018. The report “North American Molecular Diagnostics Market forecast for 2018 “analyzes the market by 2 segments such as instruments and reagents. |
Upcoming | |
North America Radioimmunoassays (RIA) The report “North American Radioimmunoassay (RIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. Radioimmunoassay accounted for about one-fifth of the share of the overall immunoassays market in 2013. |
Upcoming | |
Asia-Pacific Radioimmunoassays (RIA) Radioimmunoassay accounted for about one-third of the share of the overall immunoassays market in 2013. The report “Asia-Pacific Radioimmunoassay (RIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming | |
Europe Radioimmunoassays (RIA) Radioimmunoassay accounted for about one-fifth of the share of the overall immunoassays market in 2013. The report “European Radioimmunoassay (RIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming | |
Europe Fluorescence Immunoassays (FIA) Fluorescence immunoassays (FIA) accounted for a share of about 11.2% of the overall immunoassays market in 2012. The report “European Fluorescence immunoassays (FIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming | |
Asia Fluorescence Immunoassays (FIA) Fluorescence immunoassays (FIA) accounted for a share of about 11.2% of the overall immunoassays market in 2012. The report “Asian Fluorescence immunoassays (FIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming | |
North America Fluorescence Immunoassays (FIA) Fluorescence immunoassays (FIA) accounted for a share of about 11.2% of the overall immunoassays market in 2012. The report “North American Fluorescence immunoassays (FIA) Market forecast for 2018“ analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming | |
North America Enzyme Immunoassays (EIA) The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. The U.S. commanded the largest share of the Americas enzyme immunoassays market. The report “North American Enzyme immunoassays (EIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming | |
Europe Enzyme Immunoassays (EIA) The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. Germany commanded the largest share of the European enzyme immunoassays market. The report “European Enzyme immunoassays (EIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming | |
Asia Enzyme Immunoassays (EIA) The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. Japan commanded the largest share of the Asia-Pacific enzyme immunoassays market. The report “Asian Enzyme immunoassays (EIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming | |
Asia Chemiluminescence Immunoassays (CLIA) Japan commanded the largest share of the Asia-Pacific Chemiluminescence immunoassays (CLIA) market. The report “Asian Chemiluminescence immunoassays (CLIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. The report also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming | |
North America Chemiluminescence Immunoassays (CLIA) The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. The U.S. commanded the largest share of the North American Chemiluminescence immunoassays (CLIA) market. The report “North American Chemiluminescence immunoassays (CLIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming | |
Europe Chemiluminescence Immunoassays (CLIA) The report “European Chemiluminescence immunoassays (CLIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. Germany commanded the largest share of the European Chemiluminescence immunoassays (CLIA) market. The report also provides an extensive competitive landscaping of companies operating in this market. The major vendors in this market are Ortho Clinical Diagnostics, Inc. (U.S.), Siemens Healthcare Diagnostics (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Beckman Coulter, Inc. (U.S.), and bioMérieux (France). |
Upcoming | |
Asia Reagents & Kits The report “Asian IVD Reagents & Kits Market forecast for 2018 “analyzes the market by 2 segments such as general purpose Reagents & Kits and analyte specific Reagents & Kits. The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in IVD Reagents & Kits Market and extensively covered in this report are Abbott Laboratories, Inc., Alere, Inc., Arkray, Inc., Bayer Ag, Becton, Dickinson And Company, Biomerieux, Bio-Rad Laboratories, Inc., Danaher Corporation, Diagnostica Stago Sas, Diasorin S.P.A., Hologic, Inc., Horiba, Johnson & Johnson, Novartis International Ag, Qiagen N.V., Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, Thermo Fisher Scientific, Inc. |
Upcoming | |
North America Reagents & Kits The report “North American IVD Reagents Market forecast for 2018 “analyzes the market by 2 segments such as general purpose reagents and analyte specific reagents. The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in IVD Reagents Market and extensively covered in this report are Abbott Laboratories, Inc., Alere, Inc., Arkray, Inc., Bayer Ag, Becton, Dickinson And Company, Biomerieux, Bio-Rad Laboratories, Inc., Danaher Corporation, Diagnostica Stago Sas, Diasorin S.P.A., Hologic, Inc., Horiba, Johnson & Johnson, Novartis International Ag, Qiagen N.V., Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, Thermo Fisher Scientific, Inc. |
Upcoming |
In Vitro Diagnostics